Oracle stock falls after report reveals thin margins in AI cloud business
NORTHBROOK, Ill. - IDEX Corporation (NYSE:IEX), a $12.2 billion industrial manufacturer currently trading near its 52-week low, announced Thursday that its Board of Directors has increased the company’s share repurchase authorization to $1 billion from approximately $440 million remaining as of June 30, 2025.
The industrial manufacturer also declared a quarterly cash dividend of $0.71 per share, payable on October 24 to shareholders of record as of October 10. This marks the company’s 124th consecutive quarterly dividend payment, extending its 31-year streak of consistent dividend payments. InvestingPro data reveals the company has raised its dividend for 15 consecutive years, with several more key dividend metrics available to subscribers.
"For the full year 2025, we expect to return at least 70% of free cash flow to shareholders through dividends and share repurchases," said Eric D. Ashleman, IDEX President and Chief Executive Officer, in a press release statement.
The company has already accelerated its buyback activity in 2025, repurchasing over $100 million in shares during the first half of the year alone.
IDEX noted that the increased share repurchase authorization does not obligate the company to repurchase any specific dollar amount or number of shares, and the program may be suspended or discontinued at any time.
The company, which manufactures engineered products across three business segments - Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety/Diversified Products - operates in more than 20 countries worldwide.
According to the announcement, IDEX plans to take what it describes as a "dynamic approach" to capital allocation while investing in growth opportunities, including potential bolt-on acquisitions.
In other recent news, IDEX Corporation reported its second-quarter 2025 earnings, surpassing analysts’ expectations. The company achieved an earnings per share of $2.07, exceeding the forecast of $1.99. Additionally, IDEX reported revenue of $865 million, which was higher than the anticipated $857.93 million. Despite these positive earnings and revenue results, IDEX is facing challenges in the market. DA Davidson lowered its price target for IDEX to $180, citing incremental customer tentativeness and expected mix headwinds. Similarly, Mizuho reduced its price target for IDEX to $170, pointing to operational concerns such as tough market conditions, extended destocking, and tariffs. Both firms maintained a Neutral rating on the stock. These developments reflect ongoing market challenges and adjustments in analyst expectations for IDEX.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.